CL
TAK icon

CSS LLC’s Takeda Pharmaceutical TAK Stock Holding History

CSS LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,600
Closed -$321K – 1172
2021
Q1 		$321K Sell
17,600
-245,525
-93% -$4.42M 0.01% 667
2020
Q4 		$4.79M Sell
263,125
-37,100
-12% -$651K 0.18% 96
2020
Q3 		$5.36M Sell
300,225
-8,300
-3% -$151K 0.25% 81
2020
Q2 		$5.53M Buy
308,525
+68,900
+29% +$1.24M 0.31% 82
2020
Q1 		$3.64M Buy
239,625
+35,000
+17% +$634K 0.29% 79
2019
Q4 		$4.04M Buy
204,625
+101,180
+98% +$1.94M 0.22% 96
2019
Q3 		$1.78M Sell
103,445
-32,100
-24% -$555K 0.11% 149
2019
Q2 		$2.4M Buy
135,545
+34,370
+34% +$625K 0.14% 126
2019
Q1 		$2.06M Buy
+101,175
New +$2.04M 0.12% 124

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CSS LLC's TAK Position: Q1 2021 in Review

CSS LLC sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 54,384 shares — an estimated $978K sold.

CSS LLC first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $2.63M in Q1 2019. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

  • CSS LLC reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • CSS LLC sold 54,384 Takeda Pharmaceutical shares in Q1 2021, an estimated $978K.
  • CSS LLC first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
  • CSS LLC's Takeda Pharmaceutical position peaked at $2.63M in Q1 2019.
  • 316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.